Ligand id: 6477

Name: mogamulizumab

1. Antoniu SA. (2010)
Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.
Curr. Opin. Mol. Ther., 12 (6): 770-9. [PMID:21154168]
2. Shitara K, Nakamura K, Hosaka E, Tanaka A, Koike M. (2009)
Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens.
Patent number: US7504104. Assignee: Kyowa Hakko Kogyo Co., Ltd. Priority date: 31/08/2001. Publication date: 17/01/2010.